Apellis Pharmaceuticals Inc APLS Valuation Ratios and Share Stats

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Apellis Pharmaceuticals Inc (APLS)
Apellis Pharmaceuticals Inc (APLS) Financials

Apellis Pharmaceuticals Inc (APLS)

38.36

-3.16

(-7.61%)

Closed June 29 4:00PM

Delayed by 15 minutes

38.90

0.54

(1.41%)

After Hours: 7:56PM

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Return on Assets (%)	-82.686	-48.678	-66.121	-102.806	-51.099	-81.023	-79.437	-67.869
Return on Equity (%)	-92.307	-59.056	-82.282	-312.195	-288.855	-370.198	-353.928	-288.495
Return on Invested Capital (%)	-93.159	-51.036	-70.976	-159.27	-59.649	-119.154	-197.476	-194.822
Operating Margin (%)	N/A	N/A	N/A	N/A	-124.914	-1100.853	-820.552	-125.297
Net Profit Margin (%)	N/A	N/A	N/A	N/A	-137.594	-1121.275	-864.697	-132.537
Book Value Per Share	-3.797	2.959	2.86	0.608	2.687	2.037	1.534	1.642
Earnings Per Share	-1.509	-1.013	-2.266	-5.414	-4.53	-7.653	-5.888	-4.436
Cash Per Share	1.383	3.49	3.132	6.254	7.432	6.564	4.981	2.964
Working Capital Per Share	1.32	3.486	3.295	5.461	10.362	7.098	4.982	4.378
Operating Profit Per Share	N/A	N/A	N/A	N/A	3.292	0.68	0.63	2.868
EBIT Per Share	-1.509	-1.013	-2.266	-5.414	-4.506	-7.649	-5.881	-4.418
EBITDA Per Share	-1.509	-1.013	-2.266	-5.414	-4.506	-7.649	-5.881	-4.418
Free Cash Flow Per Share	-1.509	-1.013	-2.266	-5.388	-4.467	-7.656	-5.888	-4.444

Liquidity Ratios

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	7.521	27.772	11.891	5.674	7.147	6.25	4.293	3.095
Quick Ratio	6.832	26.8	10.353	5.353	6.849	5.402	3.346	2.257
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	89.305	414.807	134.703
Shares Outstanding	17.98M	50.33M	56.28M	56.28M	76.13M	97.52M	110.77M	N/A

Key Stats and Ratios

Year End December 30 2023	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Shares Outstanding	106.84M	N/A	110.77M	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	-379.001	N/A	N/A	N/A	-34.404
Net Profit Margin (%)	N/A	N/A	N/A	-396.419	N/A	N/A	N/A	-38.545
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	6.883	N/A	N/A	N/A	3.769
Quick Ratio	N/A	N/A	N/A	5.755	N/A	N/A	N/A	2.763
Inventory Turnover (Days)	N/A	N/A	N/A	758.006	N/A	N/A	N/A	370.901

Key Stats and Ratios

Market Cap	4.66B
Price to Earnings Ratio	-8.86
Price to Sales Ratio	11.74
Price to Cash Ratio	13.26
Price to Book Ratio	23.93
Dividend Yield	-

Share Statistics

Shares Outstanding	121.37M
Average Volume (1 week)	1.85M
Average Volume (1 Month)	1.2M
52 Week Change	-55.18%
52 Week High	92.61
52 Week Low	19.8301

More Ratios Coming Soon!

Apellis Pharmaceuticals

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions